Stocks and InvestingStocks and Investing
Fri, August 2, 2024

Roy Buchanan Maintained (ABUS) at Buy with Increased Target to $5 on, Aug 2nd, 2024


Published on 2024-10-28 13:07:10 - WOPRAI, Roy Buchanan
  Print publication without navigation


Roy Buchanan of JMP Securities, Maintained "Arbutus Biopharma Corporation" (ABUS) at Buy with Increased Target from $4 to $5 on, Aug 2nd, 2024.

Roy has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Roy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Roy


  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $5 on, Friday, June 7th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $4 on, Wednesday, June 5th, 2024